On June 22, 2022, Acorda Therapeutics Inc. (NASDAQ: ACOR) opened at $0.5847, lower -15.32% from the last session. During the day, the shares moved up to $0.6396 and dropped to $0.5225 before settling in for the closing price of $0.62. Price fluctuations for ACOR have ranged from $0.28 to $6.36 over the past 52 weeks.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -24.30%. Company’s average yearly earnings per share was noted 20.60% at the time writing. With a float of $13.11 million, this company’s outstanding shares have now reached $13.25 million.
The extent of productivity of a business whose workforce counts for 118 workers is very important to gauge. In terms of profitability, gross margin is +44.56, operating margin of -55.24, and the pretax margin is -84.51.
Acorda Therapeutics Inc. (ACOR) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Acorda Therapeutics Inc. is 1.00%, while institutional ownership is 25.50%. The most recent insider transaction that took place on Mar 17, was worth 3,895. In this transaction President and CEO of this company sold 2,289 shares at a rate of $1.70, taking the stock ownership to the 129,601 shares.
Acorda Therapeutics Inc. (ACOR) Latest Financial update
If we go through the results of last quarter, which was made public on 9/29/2021, the company posted -$1.43 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$1.56) by $0.13. This company achieved a net margin of -80.54 while generating a return on equity of -53.43. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.00% during the next five years compared to -16.40% drop over the previous five years of trading.
Acorda Therapeutics Inc. (NASDAQ: ACOR) Trading Performance Indicators
Check out the current performance indicators for Acorda Therapeutics Inc. (ACOR). In the past quarter, the stock posted a quick ratio of 1.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.30
Technical Analysis of Acorda Therapeutics Inc. (ACOR)
The latest stats from [Acorda Therapeutics Inc., ACOR] show that its last 5-days average volume of 14.56 million was superior to 0.91 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 58.13%. Additionally, its Average True Range was 0.11.
During the past 100 days, Acorda Therapeutics Inc.’s (ACOR) raw stochastic average was set at 12.23%, which indicates a significant decrease from 48.01% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 255.21% in the past 14 days, which was higher than the 135.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8456, while its 200-day Moving Average is $2.3834. Now, the first resistance to watch is $0.6006. This is followed by the second major resistance level at $0.6786. The third major resistance level sits at $0.7177. If the price goes on to break the first support level at $0.4835, it is likely to go to the next support level at $0.4444. The third support level lies at $0.3664 if the price breaches the second support level.
Acorda Therapeutics Inc. (NASDAQ: ACOR) Key Stats
There are currently 13,286K shares outstanding in the company with a market cap of 6.75 million. Presently, the company’s annual sales total 129,070 K according to its annual income of -103,950 K. Last quarter, the company’s sales amounted to 22,530 K and its income totaled -24,520 K.